Skip to Content

SEC Filings

Filing date	Form	Description	View
Sep 26, 2019	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-19-256009.pdf 0001193125-19-256009.rtf 0001193125-19-256009.xls View HTML
Sep 26, 2019	CORRESP	CORRESP	0001193125-19-256019.pdf 0001193125-19-256019.rtf 0001193125-19-256019.xls View HTML
Sep 24, 2019	DFAN14A	Additional proxy soliciting materials filed by non-management	0000921895-19-002451.pdf 0000921895-19-002451.rtf 0000921895-19-002451.xls View HTML
Sep 24, 2019	SC 13D/A	An amendment to a SC 13D filing	0000921895-19-002452.pdf 0000921895-19-002452.rtf 0000921895-19-002452.xls View HTML
Sep 20, 2019	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-19-250054.pdf 0001193125-19-250054.rtf 0001193125-19-250054.xls View HTML
Sep 20, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-250722.pdf 0001193125-19-250722.rtf 0001193125-19-250722.xls View HTML
Sep 20, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-250720.pdf 0001193125-19-250720.rtf 0001193125-19-250720.xls View HTML
Sep 19, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-249100.pdf 0001193125-19-249100.rtf 0001193125-19-249100.xls View HTML
Sep 19, 2019	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-19-249231.pdf 0001193125-19-249231.rtf 0001193125-19-249231.xls View HTML
Sep 19, 2019	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-19-249241.pdf 0001193125-19-249241.rtf 0001193125-19-249241.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2021 Merrimack Pharmaceuticals.